Overview
- 139 inspections across 120 sites are on record.
- 230 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-10-27.
At a glance
Inspections
139
Sites
120
Observations
230
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pharmaceutics International, Inc. | 27 Oct 2017 | Human Drugs | View 483 → |
| Eurofins Lancaster Laboratories, LLC | 28 Sep 2017 | Biologics | |
| Renu Laboratories, LLC | 19 Sep 2017 | Human Drugs | On file |
| Heinz Kurz GmbH Medizintechnik | 3 Aug 2017 | Medical Devices & Rad Health | On file |
| Stryker Leibinger GmbH & Co. KG | 27 Jul 2017 | Medical Devices & Rad Health |
Sites inspected
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
Eurofins Lancaster Laboratories, LLCLancaster, United States1 insp.
Renu Laboratories, LLCWarminster, United States1 insp.
Heinz Kurz GmbH MedizintechnikDuslingen, Germany1 insp.
Stryker Leibinger GmbH & Co. KGFreiburg Im Breisgau, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
James M Mason3 shared
Joseph L Despins3 shared
Temar Q Williams2 shared
Phillip M Pontikos2 shared
Jason M Sluzynski2 shared
Melanie M Walker2 shared
Dawn D Aiello2 shared
Erika M Wilkerson1 shared
Marcus A Ray1 shared
Jonathan W Chapman1 shared
Full investigator report
Get the verbatim findings behind Thomas E Friel's 230 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site